Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

10.1111/cas.14254

Saved in:
Bibliographic Details
Main Authors: Bang, Yung-Jue, Su, Wu-Chou, Schuler, Martin, Nam, Do-Hyun, Lim, Wan Teck, Bauer, Todd M, Azaro, Analia, Poon, Ronnie Tung Ping, Hong, David, Lin, Chia-Chi, Akimov, Mikhail, Ghebremariam, Samson, Zhao, Sylvia, Giovannini, Monica, Ma, Brigette
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Language:English
Published: WILEY 2022
Subjects:
Science & Technology
Life Sciences & Biomedicine
Oncology
capmatinib
MET amplification
MET dysregulation
phase 1
solid tumors
CELL LUNG-CANCER
MOLECULE INHIBITORS BINDING
C-MET
PHARMACOPHORE APPROACH
ACQUIRED-RESISTANCE
KINASE INHIBITOR
TARGETING MET
AMPLIFICATION
SENSITIVITY
MUTATIONS
Online Access:https://scholarbank.nus.edu.sg/handle/10635/218537
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English

Internet

https://scholarbank.nus.edu.sg/handle/10635/218537

Similar Items